Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
Pearse A Keane1, Srinivas R Sadda21NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK; 2Doheny Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USAAbstract: Re...
Main Authors: | Keane PA, Sadda SR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-06-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/retinal-vein-occlusion-and-macular-edema-ndash-critical-evaluation-of--a7623 |
Similar Items
-
Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
by: Roberto Gallego-Pinazo, et al.
Published: (2012-01-01) -
Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema
by: Siddhi Goel, et al.
Published: (2019-01-01) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
by: Rajvardhan Azad, et al.
Published: (2012-01-01) -
Combination of Ranibizumab and Dexamethasone intravitreal implant for macular edema secondary to retinal vein occlusion
by: Zhu Jing, et al.
Published: (2024-01-01) -
Efficacy and prognostic factors of Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Zhi-Jun Shen, et al.
Published: (2022-10-01)